News

Filter

GW Pharma posts six-month results; progresses cannabinoid pipeline including into diabetes and UC

05-06-2013

UK biopharma company GW Pharmaceuticals (AIM: GWP), which is developing and commercializing novel therapeutics…

DiabetesFinancialGastro-intestinalsGW PharmaceuticalsNeurologicalPharmaceuticalResearchSativex

GW Pharma initiates Ph IIa study of cannabinoid in diabetes

01-10-2010

UK-based GW Pharmaceuticals (GWP: AIM) has commenced the first of a program of Phase IIa exploratory…

DiabetesGW PharmaceuticalsPharmaceuticalResearch

COMPANY SPOTLIGHT

Menarini

Back to top